Hologic INC Form 4 insider transactions

Director Christiana Stamoulis reports acquisition of restricted stock units and stock options in Hologic Inc.

Director Nanaz Mohtashami reports acquisition of Hologic stock and stock options.

Director Martin D. Madaus reports acquisition of common stock and stock options in Hologic Inc.

Director Ludwig Hantson reports acquisition of common stock and stock options in Hologic Inc.

Director Charles J. Dockendorff reports acquisition of restricted stock units and stock options in Hologic Inc.

Mark W. Horvath, a Hologic Inc. executive, reports acquisition of common stock and stock options.

A Hologic Inc. executive, Brandon Schnittker, sold 90 shares of common stock to cover tax obligations related to stock awards.

Director Martin Madaus acquired restricted stock units and stock options in Hologic Inc.

Hologic's Chief Operating Officer, Mitchell Essex, exercised stock options and sold a portion of his holdings on December 4, 2024.

Hologic Inc.'s Chairman, President, and CEO, Stephen MacMillan, reported a transaction involving the withholding of shares for tax obligations and the holding of restricted stock units.

Hologic's Group President, International, Jan Verstreken, disposed of 630 shares of common stock to cover tax obligations related to vested restricted stock units.

A Hologic executive, Brandon Schnittker, sold 178 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Hologic's President of Diagnostic Solutions, Jennifer Schneiders, sold 507 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Hologic's Chief Financial Officer, Karleen Oberton, disposed of 1,332 shares of common stock to cover tax obligations related to vested restricted stock units.

Hologic Inc.'s Chief Operating Officer, Mitchell Essex, disposed of 1,341 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Hologic Inc.'s General Counsel, John M. Griffin, sold 1,120 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Hologic Inc.'s Principal Accounting Officer, Benjamin Cohn, disposed of 110 shares of common stock to cover tax obligations related to vested restricted stock units.

Hologic executive Erik S. Anderson reports the withholding of 390 shares for tax obligations related to the settlement of restricted stock units.

Hologic's CEO, Stephen MacMillan, engaged in multiple stock transactions, including tax-related disposals and the acquisition of restricted stock units and stock options.

Hologic's Group President, International, Jan Verstreken, reported multiple transactions involving company stock, including the acquisition of restricted stock units and a stock option grant.

Hologic's Division President, Brandon Schnittker, reported acquiring shares and stock options, and disposing of shares for tax obligations.

Hologic's President of Diagnostic Solutions, Jennifer Schneiders, reported multiple transactions involving company stock, including the acquisition of restricted stock units and stock options.

Hologic's Chief Financial Officer, Karleen Oberton, has reported multiple transactions involving the company's stock, including the acquisition of restricted stock units and stock options.

Hologic Inc.'s Chief Operating Officer, Mitchell Essex D., reported multiple transactions involving company stock, including the acquisition of restricted stock units and stock options, as well as the disposal of shares to cover tax obligations.

Hologic Inc.'s General Counsel, John M. Griffin, reported multiple transactions involving company stock, including the acquisition of restricted stock units and stock options, as well as the disposal of shares to cover tax obligations.

A Hologic Inc. executive, Benjamin Jordan Cohn, reported the acquisition of restricted stock units and a stock option grant, along with the disposal of shares to cover tax obligations.

Hologic's Division President, Erik S. Anderson, reported multiple transactions involving company stock, including the acquisition of restricted stock units and a stock option grant.

Hologic's CEO, Stephen MacMillan, reports acquiring 118,560 shares of common stock through performance stock units, increasing his direct and indirect holdings.

Group President, International, Jan Verstreken, reports acquisition of 17,780 shares of Hologic Inc. common stock on November 5, 2024.

Chief Financial Officer of Hologic, Karleen Marie Oberton, reports acquiring 23,710 shares of common stock on November 5, 2024, bringing her total holdings to 107,752 shares.